Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.

Name: Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.
License: Public Domain

GlaxoSmithKline

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diphtheria

tetanus, diphtheria, acellular pertussis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208251
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.